文献速递其他结缔组织病

干燥综合征患者H1N1疫苗接种触发多克隆B细胞活化并促进自身抗体产生

H1N1 vaccination in Sjögren's syndrome triggers polyclonal B cell activation and promotes autoantibody production.
PubMed 文献 · Ann Rheum Dis · 2017-07-31

本研究纳入未接受免疫调节治疗的原发性干燥综合征(pSS)患者及年龄性别匹配的健康对照,接种H1N1流感疫苗后监测血清学和细胞免疫应答。出乎意料的是,未治疗pSS患者接种后产生比健康对照更高的H1N1 IgG滴度和亲和力,但同时出现脱靶B细胞活化,导致抗EBV和自身抗体滴度升高。体外实验显示患者来源的naïve B细胞经内体TLR激活后更易分化为浆母细胞并产生更多类别转换IgG,该现象可被1型干扰素预处理在健康供者细胞中诱导,但在羟氯喹治疗患者及体外氯喹暴露后消失。

要点

  • 未治疗pSS患者接种H1N1疫苗后产生更高滴度及亲和力的H1N1 IgG,但伴随脱靶B细胞活化。
  • 接种后抗EBV和自身抗体滴度升高,提示疫苗可能促进自身抗体产生。
  • 患者naïve B细胞经内体TLR激活后更易分化为浆母细胞并产生更多类别转换IgG。

核心结论

  • 未治疗pSS患者对H1N1疫苗的体液免疫应答增强而非减弱,但伴随多克隆B细胞活化和自身抗体产生增加。
  • 内体TLR激活和1型干扰素通路参与pSS中B细胞过度活化,羟氯喹可抑制该过程。
  • 对未治疗自身免疫病患者接种疫苗需谨慎权衡。

研究设计与样本

  • 研究纳入未接受免疫调节治疗的原发性干燥综合征患者及年龄性别匹配的健康对照,接种H1N1流感疫苗。
  • 监测血清学和细胞免疫应答,并用标准化表格记录临床症状。
  • 体外实验在纯化naïve B细胞中诱导IgG类别转换和浆细胞分化,采用NanoString技术评估基因表达。

主要发现

  • 未治疗pSS患者接种后H1N1 IgG滴度高于健康对照,且亲和力更高。
  • 接种后脱靶B细胞被触发,抗EBV和自身抗体滴度升高。
  • 体外内体TLR激活后,患者来源naïve B细胞更易分化为浆母细胞并产生更多类别转换IgG。
  • 1型干扰素预处理健康供者细胞可诱导浆细胞分化和类别转换增强,但在羟氯喹治疗患者细胞中及体外氯喹暴露后该现象消失。

临床怎么用

  • 对未接受免疫调节治疗的pSS患者接种疫苗时,应关注自身抗体和抗EBV滴度的变化。
  • 羟氯喹治疗可能抑制疫苗诱导的B细胞过度活化和自身抗体产生。

局限性

  • 研究主要针对未治疗pSS患者,结果外推至其他自身免疫病或接受免疫抑制治疗患者需谨慎。
  • 原文未报告样本量、具体数值及统计显著性指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Vaccination of patients with rheumatic disease has been reported to result in lower antibody titres than in healthy individuals. However, studies primarily include patients on immunosuppressive therapy. Here, we investigated the immune response of treatment-naïve patients diagnosed with primary Sjögren's syndrome (pSS) to an H1N1 influenza vaccine. METHODS: Patients with Sjögren's syndrome without immunomodulatory treatment and age-matched and gender-matched healthy controls were immunised with an H1N1 influenza vaccine and monitored for serological and cellular immune responses. Clinical symptoms were monitored with a standardised form. IgG class switch and plasma cell differentiation were induced in vitro in purified naïve B cells of untreated and hydroxychloroquine-treated patients and healthy controls. Gene expression was assessed by NanoString technology. RESULTS: Surprisingly, treatment-naïve patients with Sjögren's syndrome developed higher H1N1 IgG titres of greater avidity than healthy controls on vaccination. Notably, off-target B cells were also triggered resulting in increased anti-EBV and autoantibody titres. Endosomal toll-like receptor activation of naïve B cells in vitro revealed a greater propensity of patient-derived cells to differentiate into plasmablasts and higher production of class switched IgG. The amplified plasma cell differentiation and class switch could be induced in cells from healthy donors by preincubation with type 1 interferon, but was abolished in hydroxychloroquine-treated patients and after in vitro exposure of naïve B cells to chloroquine. CONCLUSIONS: This comprehensive analysis of the immune response in autoimmune patients to exogenous stimulation identifies a mechanistic basis for the B cell hyperactivity in Sjögren's syndrome, and suggests that caution is warranted when considering vaccination in non-treated autoimmune patients.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Brauner S, Folkersen L, Kvarnström M, et al. H1N1 vaccination in Sjögren's syndrome triggers polyclonal B cell activation and promotes autoantibody production. Ann Rheum Dis. 2017. PMID: 28760805. doi:10.1136/annrheumdis-2016-210509

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。